Autonomic Dysfunction in Functional Dysphonia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity Ghent

About this trial

The first objective of this research project is to compare the occurrence and frequency of symptoms and/or disorders related to autonomic dysfunction in patients with functional dysphonia with gender- and age-matched vocally healthy controls, using a case-control study.

The second objective is to compare the effects of a novel therapy based on autonomic nervous system regulation (i.e., ANS therapy: heart rate variability biofeedback), for functional dysphonia versus coventional voice therapy (CVT) alone or in combination with ANS regulation therapy (i.e., ANS therapy + CVT), using a longitudinal randomized controlled trial (RCT).

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • ANS regulation therapy
  • conventional voice therapy (CVT)
  • ANS regulation therapy + CVT

Treatment groups

100 Participants
are divided into 3 treatment groups

Sponsors and collaborators

University Ghent

Lead sponsor

Universiteit Antwerpen

Collaborator

University of Utah

Collaborator